This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sato, H.
Right arrow Articles by Feix, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, H.
Right arrow Articles by Feix, J. B.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2008, p. 4463-4465, Vol. 52, No. 12
0066-4804/08/$08.00+0     doi:10.1128/AAC.00810-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Lysine-Enriched Cecropin-Mellitin Antimicrobial Peptides with Enhanced Selectivity {triangledown}

Hiromi Sato1 and Jimmy B. Feix2*

Department of Microbiology and Molecular Genetics and Center for Biopreparedness and Infectious Disease,1 Department of Biophysics, Medical College of Wisconsin, Milwaukee, Wisconsin 532262

Received 19 June 2008/ Returned for modification 4 August 2008/ Accepted 7 October 2008

Lysine-enriched analogs of the cecropin-mellitin hybrid peptide, CA1-7 M2-9 (designated CM15), designed with optimized amphipathicity, retained antimicrobial activities similar to that of wild-type CM15 and had substantially reduced levels of hemolytic activity and cytotoxicity toward cultured macrophages, resulting in enhanced selectivity. These lysine-enriched analogs provide templates for improved CM15 peptide or peptidomimetic antibiotics.


* Corresponding author. Mailing address: Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226. Phone: (414) 456-4037. Fax: (414) 456-6512. E-mail: jfeix{at}mcw.edu

{triangledown} Published ahead of print on 13 October 2008.


Antimicrobial Agents and Chemotherapy, December 2008, p. 4463-4465, Vol. 52, No. 12
0066-4804/08/$08.00+0     doi:10.1128/AAC.00810-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Taguchi, S., Mita, K., Ichinohe, K., Hashimoto, S. (2009). Targeted Engineering of the Antibacterial Peptide Apidaecin, Based on an In Vivo Monitoring Assay System. Appl. Environ. Microbiol. 75: 1460-1464 [Abstract] [Full Text]